Pharmacology News and Research

Latest Pharmacology News and Research

NYU Langone scientists identify promising treatment target for Alzheimer's disease

NYU Langone scientists identify promising treatment target for Alzheimer's disease

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

P2Y12 and blood clotting: an interview with Dr. Jacobson, NIH

AMRI agrees to acquire OsoBio for $110 million

AMRI agrees to acquire OsoBio for $110 million

Study suggests new targets for treating rare genetic disorder and cancer

Study suggests new targets for treating rare genetic disorder and cancer

Researchers identify new therapeutic target for treating most common form of eye cancer

Researchers identify new therapeutic target for treating most common form of eye cancer

UT Southwestern researchers identify protein critical to the spread of deadly cancer cells

UT Southwestern researchers identify protein critical to the spread of deadly cancer cells

Case Western Reserve physician calls on FDA to address hidden risk of dangerous drugs side effects

Case Western Reserve physician calls on FDA to address hidden risk of dangerous drugs side effects

Study examines potential use of medical marijuana, CBD in treating epilepsy

Study examines potential use of medical marijuana, CBD in treating epilepsy

TUSM scientists receive $11.5M grant to develop innovative treatments for heart failure

TUSM scientists receive $11.5M grant to develop innovative treatments for heart failure

Professor receives grant to study stress-induced hypertension, its effects on neuroimmune system

Professor receives grant to study stress-induced hypertension, its effects on neuroimmune system

Substance from pine bark is a potential source for treating melanoma

Substance from pine bark is a potential source for treating melanoma

Space Station science: Microgravity on human thyroid carcinoma cells

Space Station science: Microgravity on human thyroid carcinoma cells

The future of high throughput screening: an interview with Mark Wigglesworth, Director High Throughput Screening, AstraZeneca

The future of high throughput screening: an interview with Mark Wigglesworth, Director High Throughput Screening, AstraZeneca

Three Chicago-area universities to share research facilities at reduced cost

Three Chicago-area universities to share research facilities at reduced cost

PAREXEL International launches Perceptive MyTrials Data-Driven Monitoring solution

PAREXEL International launches Perceptive MyTrials Data-Driven Monitoring solution

KineMed extends collaboration with CHDI Foundation to track pathogenesis of Huntington's disease

KineMed extends collaboration with CHDI Foundation to track pathogenesis of Huntington's disease

Young adults who smoke water pipes have elevated levels of tobacco-related cancer-causing agents

Young adults who smoke water pipes have elevated levels of tobacco-related cancer-causing agents

UH pharmacy students earn awards for excellence in leadership, professional service and clinical skills from TSHP

UH pharmacy students earn awards for excellence in leadership, professional service and clinical skills from TSHP

Study: Lorazepam drug not effective in treating pediatric status epilepticus

Study: Lorazepam drug not effective in treating pediatric status epilepticus

Cryogenically-cooled technology significantly enhances current capabilities of cardiac and brain MRI in mice

Cryogenically-cooled technology significantly enhances current capabilities of cardiac and brain MRI in mice

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.